FDA Advisory Committees Decline & Biosimilar Rule Changes
FDA faces scrutiny over a 63% drop in advisory committee meetings in 2025 and new moves to ease biosimilar development requirements in 2026.
Keala Nakamura
Editor-in-Chief
Clinical Research MethodologyInternal MedicineEvidence-Based MedicineEditorial Leadership
About Keala
Keala Nakamura is an internal medicine specialist and clinical researcher at Queen's Medical Center, Honolulu. Previously on the editorial staff of the New England Journal of Medicine, she brings two decades of experience in clinical research methodology and evidence-based medicine to her role leading Hawaii Medical Journal.